Biosplice Announces Collaboration with Novo Nordisk in Diabetes
13. Juni 2024 06:00 ET
|
Biosplice Therapeutics, Inc.
Biosplice enters into a pre-clinical collaboration with Novo Nordisk to develop inhibitors of DYRK for diabetes